ChinaBio(R) LLC Release: China Takes First Place As Asia’s Leading Biopharma Cluster
4/3/2014 1:58:24 PM
April 3, 2014 -- China is Asia’s number one biopharma cluster, according to a ranking system devised by Genetic Engineering & Biotechnology News. The country won the top spot because it led all other countries in biomedical R&D spending ($160 billion out of $243 billion in all of Asia), the number of life science companies (7,500 last year), the total number of industry jobs (over 250,000), and venture capital investment ($74 million to five companies). China was second to Japan in IPOs ($2.1 billion raised by 14 companies since 2010) while its 9,302 biotech/pharma patents (apparently counted from 1970 to the present) were in third place overall. More details....
Help employers find you! Check out all the jobs and post your resume.
comments powered by